Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.

Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.
Hearing loss in patients with vestibular schwannoma, both before and after treatment, is known to negatively impact quality of life.
Despite the increased morbidity and risks associated with revision surgery, select patients benefit from re-operation in the setting of recurrent well-differentiated thyroid cancer.
Patients with head and neck cancer enrolled in randomized clinical trials evaluating interventions to improve outcome are much younger and have a very good performance status compared to patients seen in clinical practice, […]
In May, the U.S. Food and Drug Administration approved dupilumab (Dupixent) as a treatment for eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least […]
Barriers in care access for head and neck cancer patients can be categorized as delays in presentation, referral, and treatment, and insights gained suggest the feasibility and transferability in developing strategies for early detection.
Septorhinoplasty with spreader graft placement with and without upper lateral cartilage release provides clinically and statistically significant improvement.
A look at how procedural therapies compare to other established pharmacologic and nonpharmacologic methods in treating patients with neurogenic cough.
SARS-CoV-2 can infect human inner ear cell types, and this infection may underlie COVID-19–associated problems with hearing and balance.